Angina
Pathophysiology and Epidemiology of Coronary Artery Disease
Definition of Coronary Artery Disease (CAD):
Ischaemic heart disease, predominantly manifesting as coronary artery disease, is primarily caused by atherosclerosis.
Atherosclerosis involves the progressive build-up of fatty deposits, lipid pools, and fibrous scar tissue within the walls of coronary arteries, which progressively diminishes luminal diameter and impedes myocardial blood flow.
Stages of Atheroma Progression and Clinical Sequelae:

Normal Artery Architecture: Composed of concentric layers: the innermost single-cell endothelium, the tunica intima, the tunica media containing smooth muscle cells, and the adventitia.
Early Atheroma: Initiated by endothelial dysfunction and subendothelial accumulation of lipids, giving rise to early fatty streaks and plaque formation within the intima.
Stabilized Plaque: Characterized by a small central lipid pool protected by a thick fibrous cap. This morphology preserves the arterial lumen and presents a low immediate rupture risk.
Vulnerable Plaque: Characterized by a large, lipid-rich core, an abundance of infiltrating inflammatory cells (such as macrophages), and a thin, fragile fibrous cap prone to mechanical disruption.
Thrombosis of a Ruptured Plaque: Plaque rupture exposes thrombogenic lipid core material to circulating platelets and coagulation factors, inducing rapid thrombus formation over the rupture site.
Outcomes of Plaque Disruption:
Acute Myocardial Infarction: Complete or critical occlusion of major epicardial vessels (such as the left coronary arteries or right coronary artery) cuts off perfusion downstream, causing irreversible myocardial tissue necrosis.
Healed Ruptured Plaque: Organization and fibrotic repair of the thrombus leads to a severely narrowed arterial lumen enveloped by a dense, fibrous intima.
Epidemiological Profile and Morbidity (British Heart Foundation 2019 Data):
Approximately individuals die every single day from coronary artery disease in the United Kingdom.
Coronary artery disease is the leading cause of death worldwide.
There are approximately () individuals living with coronary heart disease in the United Kingdom.
Marked geographical disparities exist across the UK for premature coronary heart disease death rates (per population, surveyed between 2015 and 2017):
Premature death rate tiers: , , , , and .
The highest premature mortality rates occur in Scotland and Northern England.
The lowest mortality rates are concentrated in South East England.

Risk Factor Stratification for Atherosclerosis:
Age: Predominantly develops and presents clinically in middle age and older cohorts.
Sex: Males display an elevated baseline risk compared to premenopausal females; however, female susceptibility increases after menopause, eventually matching male incidence.
Genetics vs. Lifestyle: The precise relative contributions of inherited genetic predispositions versus acquired environmental and lifestyle choices remain difficult to dissect.
Smoking: Directly linked to to of all coronary artery disease deaths.
Obesity and Dyslipidemia: The ratio of high-density lipoprotein to low-density lipoprotein (), rather than absolute total cholesterol concentration (), serves as the key predictor and is linked to of CAD fatalities.
Alcohol Consumption: Light consumption ( per week) is correlated with potentially cardioprotective effects.
Clinical Classification and Etiology of Angina Pectoris
Pathophysiological Basis of Anginal Pain:
Angina pectoris is the characteristic chest pain associated with coronary heart disease (CHD).
Occurs when severe imbalance between myocardial oxygen supply and myocardial oxygen demand produces cardiac ischemia (hypoxia).
Local hypoxia triggers the metabolic discharge of nociceptive stimulators, specifically protons () and adenosine triphosphate (), which activate sensory pain receptors on cardiac nerve fibers.
Prevalence and Historical Description:
Angina affects approximately () individuals in the United Kingdom.
Angina symptoms are responsible for of all hospital emergency admissions in the UK.
First described clinically in 1768 by English physician William Heberden (1710–1801), who initially characterized angina pectoris as an "extremely rare" clinical disorder.
Stable Angina:
Etiology: Coronary arteries are severely narrowed by fixed, stable atherosclerotic plaques; residual basal blood flow is barely sufficient to meet myocardial oxygen demands at rest.
Exertional Pattern: Induced predictably by physical exercise or exertion when myocardial workload escalates; relieved promptly by rest or cessation of effort.
Diagnostic Threshold: Clinical symptoms and ischemic thresholds must remain unchanged for .
Unstable Angina:
Etiology: A high-risk, deteriorating condition where acute luminal obstruction is caused by thrombus formation superimposed on ruptured or fissured plaques (a blood clot has formed directly on top of a cracked or torn cholesterol buildup inside an artery), resulting in severe dynamic obstruction.
Clinical Presentation: Strongly associated with imminent acute myocardial infarction; characterized by accelerating frequency, escalating severity, and eventual occurrence of ischemic chest pain at rest.
Distinct Variants:
Decubitus Angina: Anginal episodes triggered specifically when the patient assumes a recumbent or supine position, caused by the gravitational redistribution of venous volume augmenting ventricular pre-load.
Nocturnal Angina: Anginal episodes occurring during sleep, frequently provoked by vivid dreaming states that stimulate acute sympathetic discharge and elevate heart rate.
Coronary Artery Spasm (Prinzmetal / Vasospastic Angina):
Etiology: Caused by abrupt, transient hyper-reactivity and intense spasm of vascular smooth muscle within epicardial coronary arteries, inducing severe transient vasoconstriction.
Clinical Features: Often presents in patients without underlying obstructive coronary atheroma.
Precipitating Triggers: Provoked by exposure to cold environments, sudden physical exertion, intense psychological stress, or acute emotional episodes.
Diagnostic Confirmation: Diagnosed definitively using coronary angiography.
Microvascular Angina:
Etiology: A non-classical coronary presentation characterized by functional or structural obstruction within the microscopic coronary arterioles and microvasculature supplying the myocardium, rather than epicardial artery stenosis.
Mechanisms: Caused by genetic or hormonal abnormalities that disrupt endogenous endothelial-dependent vasodilation.
Risk Profile: Strong clinical association with insulin resistance and chronic systemic inflammation; exhibits a higher prevalence in women.
Therapeutic Interventions and Surgical Strategies
Pharmacological Management of Stable Angina:
Long-term primary prevention involves 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) paired with antiplatelet therapy, most commonly low-dose aspirin.
Symptomatic medical therapy focuses on reducing cardiac workload and modifying cardiac output via:
Organic nitrates.
Calcium () channel antagonists.
Sympathetic nervous system inhibitors (beta-adrenoceptor blockers).
Surgical and Percutaneous Revascularization in Unstable Disease:
Coronary Artery Bypass Grafting (CABG): Surgical rerouting of coronary circulation around critical stenoses using autologous vessels:
Saphenous Vein Graft: Harvested from the lower extremity and anastomosed proximally to the ascending aorta and distally to the target coronary artery downstream of the blockage.
Left Internal Mammary Artery (LIMA) Graft: Mobilized from the anterior chest wall and anastomosed directly to the coronary vessel (such as the left anterior descending artery) distal to the obstructive atheroma.

Percutaneous Coronary Intervention (PCI) with Stenting: Catheter-based luminal restoration consisting of sequential procedural steps:
Stent Insertion: A crimped, expandable metallic mesh stent mounted over a deflated balloon catheter is guided fluoroscopically across the atherosclerotic plaque lesion.
Stent Expansion: The balloon catheter is inflated to high pressure, radially expanding the metallic stent against the arterial wall, which compresses the atheroma and dilates the restricted lumen.
Stent Retention: The balloon is deflated and withdrawn from the vascular tree, leaving the expanded metallic scaffold permanently deployed to prevent elastic recoil and restenosis.

Reperfusion Injury Complications:
Mechanisms: Prolonged tissue hypoxia causes metabolic reprogramming within ischemic cardiomyocytes. Sudden reintroduction of oxygenated blood upon revascularization initiates severe local oxidative stress and an acute inflammatory cascade.
Consequences: Unchecked, sustained reperfusion inflammation drives massive leukocyte accumulation and adherence, precipitating extensive programmed cell death (PCD) and secondary myocardial necrosis.
Therapeutic Mitigation: Co-administration of anti-inflammatory pharmacological agents during revascularization minimizes leukocyte extravasation and attenuates reperfusion injury.
Organic Nitrates: Chemistry, Hemodynamics, and Vascular Actions
Evolution and Chemical Characteristics of Nitrates:
Amyl Nitrite: Originally introduced in 1867 as an alternative to venesection (bloodletting). It is a highly volatile aliphatic ester that produces rapid vasodilation within minutes to alleviate angina pain, but causes marked systemic off-target adverse effects.

Glyceryl Trinitrate (GTN / Nitroglycerin): The clinical mainstay for acute anginal episodes; an organic nitrate ester comprising three nitrate groups esterified to a glycerol backbone.

Isosorbide Mononitrate: A heterocyclic organic nitrate derivative characterized by extended metabolic stability and longer biological half-life, making it suitable for chronic prophylactic therapy.

Pharmacokinetic Limitations of Glyceryl Trinitrate:
Rapid Clearance and Brief Duration: Acute vasodilatory effects initiate within but persist for only , with complete systemic elimination occurring within .
Prophylactic Failure: Due to its fleeting half-life, sublingual GTN cannot serve as a chronic prophylactic agent and fails to protect against episodes of nocturnal angina.
Systemic Hemodynamic Effects:
Smooth muscle relaxation is achieved primarily via enzymatic bioconversion into nitric oxide ().
Venodilation (Pre-load Reduction): Markedly dilates large systemic capacitance veins, reducing venous return to the right heart and lowering end-diastolic ventricular filling pressure (pre-load).
Arterial Dilation (After-load Reduction): Dilates large conduit arteries, reducing total peripheral resistance and systemic vascular resistance, thereby diminishing left ventricular work and after-load.
Epicardial Coronary Vasodilation: Directly relaxes large epicardial coronary vessels, alleviating vasospasm and enhancing perfusion directed to under-perfused myocardium.
Multi-drug Regimens: Co-administration of long-acting nitrate formulations with calcium () channel antagonists and -blockers markedly improves clinical prognosis and symptom control in stable angina.
Cellular and Molecular Signaling Pathway of Nitrates
Step-by-Step Intracellular Signaling Cascade:
Step 1 (Denitration and Thiol Interaction): Intracellular uptake of glyceryl trinitrate (GTN) undergoes bioactivation via reaction with sulfhydryl groups ( groups / thiols), generating nitric oxide ().
Step 2 (Guanylate Cyclase Activation): The generated diffuses rapidly and binds to the heme moiety of soluble Guanylate Cyclase, stimulating its catalytic activity.
Step 3 (Cyclic GMP Synthesis): Activated Guanylate Cyclase converts intracellular guanosine triphosphate () into cyclic guanosine monophosphate ().
Step 4 (Protein Kinase G Activation): Elevated levels of intracellular allosterically activate Protein Kinase G ().
Step 5 (Calcium Clearance and Dephosphorylation): Activated Protein Kinase G mediates two distinct actions:
PKG stimulates active transport channels in the sarcoplasmic reticulum (), pumping free cytosolic calcium () ions into the lumen, which lowers cytosolic .
PKG promotes the dephosphorylation of phosphorylated myosin light chain () back into its unphosphorylated form ().
Step 6 (Vascular Smooth Muscle Relaxation): Dephosphorylation of myosin light chain prevents actin-myosin cross-bridge cycling and force generation, producing smooth muscle relaxation and vasodilation.
Hemodynamics of Vascular Steal vs. Collateral Perfusion
Pathology of Vascular Steal Induced by Non-Selective Vasodilators:
In a branched coronary arterial tree where an atheroma severely restricts flow down one arterial branch, the microvascular resistance vessels in the ischemic distal territory are already maximally dilated by local hypoxia and metabolic by-products (, , adenosine).
Typical non-selective vasodilators (such as dipyrimidine / dipyridamole) only relax and dilate non-ischemic resistance arterioles in adjacent healthy myocardial zones.
Because vascular resistance plummets in the healthy vascular branch while remaining fixed in the obstructed branch, incoming coronary blood preferentially shunts along the path of least resistance into healthy tissue.
This process siphons blood flow away from the compromised ischemic territory, a phenomenon termed vascular steal, which worsens local myocardial ischemia.
Collateral Dilation by Organic Nitrates:
Collateral circulation comprises normally dormant inter-arterial anastomotic connections linking adjacent branches of the coronary tree.
Unlike typical arteriolar vasodilators, organic nitrates dilate both epicardial conductance arteries and dormant collateral vessels.
Opening these collateral channels permits blood from unobstructed arterial branches to cross over into the post-stenotic segment, redirecting flow into the ischemic zone and avoiding vascular steal.

Clinical Adverse Effects, Nitrate Tolerance, and Historical Toxicology
Headaches and Nitrate Tachyphylaxis:
Severe Cephalea: Marked dilation of meningeal and cerebral arteries elicits intense, throbbing headaches ("cracking headaches").
Pharmacological Tolerance: Continuous, round-the-clock administration leads to rapid attenuation of therapeutic efficacy (tachyphylaxis).
Mechanism of Tolerance: Driven by intracellular depletion of sulfhydryl () donors required for nitrate bioactivation and desensitization of soluble Guanylate Cyclase.
High-Risk Agents: Tolerance develops prominently with long-acting organic nitrates, including isosorbide derivatives (such as isosorbide mononitrate).
Clinical Mitigation: Avoided by establishing eccentric dosing regimens that incorporate a daily nitrate-free interval of .
Postural Hypotension:
Excessive systemic venous pooling upon standing reduces central venous return and cardiac stroke volume.
The resulting fall in systemic arterial pressure can overwhelm normal baroreceptor reflexes that constrict peripheral vessels in the lower limbs, causing orthostatic hypotension, cerebral hypoperfusion, and syncope.
Historical Industrial Toxicology: The Canary Girls of Chilwell:
During World War I, female munitions workers at manufacturing sites—such as the Chilwell filling factory in 1917—handled munitions packed with nitrate-based explosives (cordite and TNT).
They were dubbed "Canary girls" because occupational exposure to toxic nitrate and nitro-aromatic compounds dyed their skin, hair, and mucous membranes bright yellow.
Occupational Nitrate Tolerance and "Monday Disease":
Continuous percutaneous and respiratory absorption of organic nitrates during the workweek induced persistent vasodilation and subsequent compensatory vascular tolerance.
Over weekend breaks, clearance of nitrates allowed vascular tone to normalize while resetting physiological tolerance.
Upon re-exposure every Monday, workers suffered severe rebound cardiovascular symptoms, including pounding headaches and acute tachycardia ("Monday disease").
Conversely, weekend nitrate withdrawal occasionally provoked reflex coronary vasospasm and myocardial ischemia due to unopposed compensatory vasoconstriction.

Comparative Pharmacological Approaches in Angina Therapy
Primary Therapeutic Objective:
The core goal across all antianginal management is the reduction of myocardial oxygen consumption () to restore balance with impaired coronary supply.
Short-acting organic nitrates accomplish this primarily by reducing ventricular pre-load and after-load.
Cardiovascular Actions of -Adrenoceptor Antagonists:
Reduction in Myocardial Oxygen Demand: -blockers antagonize myocardial -adrenergic receptors, decreasing baseline heart rate (negative chronotropy) and contractile force (negative inotropy).
Preservation of Collateral Perfusion (No Vascular Steal): -blockers exert negligible direct vasodilatory action on coronary resistance arterioles, preventing the adverse redistribution seen with arteriolar dilators and avoiding vascular steal.
Blood Pressure and Afterload Reduction: Sparing heart rate reduces systemic systolic blood pressure and overall afterload.
Diastolic Perfusion Optimization: Coronary perfusion occurs predominantly during diastole. By slowing heart rate, -blockers prolong the duration of diastole, which enhances coronary perfusion time.
Antiarrhythmic Efficacy: Maintaining a stable, suppressed resting heart rate attenuates the risk of fatal cardiac dysrhythmias, which are a major cause of mortality in coronary heart disease.